Forwarded from Chief Nerd
Study Finds Rate of Guillain-Barré Syndrome After Pediatric COVID-19 Vaccination is 7x That of the Flu Vaccine
“The study, presented at the 2022 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) annual meeting, September 21-24, in Nashville, Tennessee, compared the rate of pediatric GBS following COVID-19 vaccination to the rate after influenza, human papillomavirus (HPV), and meningococcal vaccinations.
Between vaccinations, the reporting rate of GBS after COVID-19 vaccination was significantly higher than the others, at 12.45 per 10 million (P <.005), followed by influenza (1.63), meningococcal (1.19), and HPV vaccinations (1.07).”
https://www.neurologylive.com/view/potential-increased-risk-guillain-barr-syndrome-pediatric-patients-following-covid-19-vaccination
@ChiefNerd
“The study, presented at the 2022 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) annual meeting, September 21-24, in Nashville, Tennessee, compared the rate of pediatric GBS following COVID-19 vaccination to the rate after influenza, human papillomavirus (HPV), and meningococcal vaccinations.
Between vaccinations, the reporting rate of GBS after COVID-19 vaccination was significantly higher than the others, at 12.45 per 10 million (P <.005), followed by influenza (1.63), meningococcal (1.19), and HPV vaccinations (1.07).”
https://www.neurologylive.com/view/potential-increased-risk-guillain-barr-syndrome-pediatric-patients-following-covid-19-vaccination
@ChiefNerd